You are here

The Death of Hormone Replacement Therapy — Why and how to use Ovarian Hormone Therapy

A response to the cancelled Women's Health Initiative study and call for a healthier look at menopause

Dr. Jerilynn C. Prior, Scientific Director of the Centre for Menstrual Cycle and Ovulation Research, has never advocated the use of hormones as an ongoing "replacement" for menopause. She does not feel that menopause is a medical condition that needs to be "fixed". Rather it is a normal stage of life. She strongly advocates use of new term for the few women who do need therapy in menopause. The new term is: Ovarian Hormone Therapy. Dr. Prior says there are only three main reasons for recommending OHT for a menopausal woman:

  1. if a woman is experiencing early menopause (<40 or <45 with hot flushes or low bone density);
  2. hot flushes are disturbing, especially when they interfere with sleep;
  3. for treatment of osteoporosis especially in women with hot flushes.

For hot flushes progesterone, like estrogen, is effective. Dr. Prior also states OHT should only be taken longer than five years if menopause came too early. She has never advocated OHT for prevention of heart disease. Dr. Prior believes menopause is a normal part of a woman's life cycle. It is not, in general, something that needs medical "treatment." She prefers the term "ovarian hormone therapy" because it more correctly describes treatment for those who need it. Some women do have sufficiently disturbing hot flushes or osteoporosis that short term treatment is appropriate.

Be sure to read Dr. Prior's article "Estrogen Deficiency: The Wrong Idea About Menopause" also found on this site. Click here for more detailed information about the early curtailment of the WHI study and Dr. Prior's thoughts on when and why to use ovarian hormone therapy.

Type: 
Articles
Life Phase: 
Menopause
Updated Date: 
April 8, 2014

Join a Study:

Enrolment complete: Perimenopausal Hot Flush Study

Enrolment is now complete. Thank you for your interest.
CeMCOR is now recruiting Canadian women for this CIHR-funded randomized controlled trial to test whether oral micronized progesterone is more effective than placebo as therapy for hot flushes and night sweats in perimenopausal women.

LEARN MORE

 

Get Involved

Volunteer research participants are the heart of all CeMCOR research. Participants are invited to provide feedback on study processes, to learn their own results and at the end of a study, be the first to hear what the whole study found. Please become a CeMCOR research participant—you can contribute to improving the scientific information available for daughters, friends and the wider world of women.